Skip to content

Alpha-1 Foundation DNA and Tissue Bank

Alpha-1 Foundation DNA and Tissue Bank

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00884455
Enrollment
5000
Registered
2009-04-20
Start date
2002-12-31
Completion date
2033-06-10
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alpha 1 Antitrypsin Deficiency

Keywords

tissue banking, research

Brief summary

This is a long-term follow-up banking protocol that collects medical information and tissue (blood, liver and lung) samples for future research; use of data and samples for research purposes is overseen by the Tissue Bank Advisory Committee; the purpose of the Bank is to further research on alpha-1 antitrypsin deficiency.

Detailed description

Subject participation includes completion of informed consent, medical questionnaire, and email authorization. Subjects may provide a blood sample for alpha-1 antitrypsin genotype, phenotype and level. Lung and liver tissue may also be provided if available. Subjects may be contacted no more often than annually for updated information. This project has a certificate of confidentiality from NIH.

Interventions

None listed

Sponsors

Alpha-1 Foundation
CollaboratorOTHER
University of Florida
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* all interested individuals may enroll

Exclusion criteria

* there are no

Design outcomes

Primary

MeasureTime frameDescription
Data and tissue samplesThe total number of tissue samples received and used for research are tracked annually.At the end of 15 years the tissue and data sample usage will be analyzed to determine continuation of the project. Each year the investigator provides a summary to the Alpha-1 Foundation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026